RXL:NYE-ProShares Ultra Health Care (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 108.1498

Change

-2.17 (-1.97)%

Market Cap

N/A

Volume

2.96K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-03 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B..

+0.25 (+0.72%)

USD 12.27B
QLD ProShares Ultra QQQ

-0.16 (-0.16%)

USD 7.32B
FNGU MicroSectors FANG+ Index 3X Le..

+5.05 (+1.27%)

USD 5.28B
SSO ProShares Ultra S&P500

-0.33 (-0.37%)

USD 5.17B
UPRO ProShares UltraPro S&P500

-0.47 (-0.56%)

USD 4.05B
TECL Direxion Daily Technology Bull..

+1.16 (+1.40%)

USD 3.28B
USD ProShares Ultra Semiconductors

+4.39 (+3.80%)

USD 1.18B
YINN Direxion Daily FTSE China Bull..

-3.75 (-7.43%)

USD 1.15B
LABU Direxion Daily S&P Biotech Bul..

-5.34 (-4.25%)

USD 0.94B
DPST Direxion Daily Regional Banks ..

+0.71 (+0.80%)

USD 0.80B

ETFs Containing RXL

KGHG 4.13 % 0.00 %

N/A

N/A
IEUS iShares MSCI Europe Small.. 0.00 % 0.40 %

-0.42 (0%)

USD 0.10B
SCZ iShares MSCI EAFE Small-C.. 0.00 % 0.39 %

-0.58 (0%)

USD 9.37B
LGWU:F Lyxor Index Fund - Lyxor .. 0.00 % 0.00 %

-2.90 (0%)

N/A
ZPRX:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

-0.40 (0%)

USD 0.25B
ZPRX:XETRA SPDR® MSCI Europe Small .. 0.00 % 0.00 %

-0.11 (0%)

USD 0.17B
1388:TSE 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 18.32% 45% F 78% C+
Dividend Return 0.85% 39% F 14% F
Total Return 19.17% 45% F 74% C
Trailing 12 Months  
Capital Gain 31.38% 18% F 75% C
Dividend Return 1.15% 22% F 13% F
Total Return 32.52% 16% F 71% C-
Trailing 5 Years  
Capital Gain 120.32% 77% C+ 88% B+
Dividend Return 2.98% 44% F 9% A-
Total Return 123.29% 77% C+ 87% B+
Average Annual (5 Year Horizon)  
Capital Gain 15.49% N/A N/A 79% B-
Dividend Return 15.71% N/A N/A 75% C
Total Return 0.22% N/A N/A 6% D-
Risk Return Profile  
Volatility (Standard Deviation) 27.14% N/A N/A 38% F
Risk Adjusted Return 57.88% N/A N/A 74% C
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike